Alexandria Real Estate Equities, Inc., an urban office REIT focused on collaborative life science, and innovation cluster locations, announced that Bristol Myers Squibb has executed a long-term lease for the development of the company’s newest core R&D facility, a 427,000 sq.-ft. world-class building at Alexandria Point in the heart of the University Town Center (UTC) submarket in San Diego. Alexandria Point is the company’s first leading-edge, highly sustainable amenity-rich mega campus.

 

This milestone lease marks the second-largest life science lease in Alexandria’s history and further enhances its long-term strategic relationship with BMS. Since 1998, Alexandria has strategically partnered with BMS, aggregating over 900,000 sq.-ft. across five of Alexandria’s cluster markets, San Diego, Greater Boston, the San Francisco Bay Area, New York City and Seattle.

 

“BMS looks forward to bringing our teams across San Diego to work together at our new innovative research hub,” said Rupert Vessey, executive vice president, Research and Early Development of Bristol Myers Squibb. “Having a single campus will accelerate collaboration amongst our company’s research teams and will foster a flexible working ecosystem to further BMS’s mission to advance medicines for patients who need them most.” 

 

When complete, Alexandria Point will provide more than 2 million sq.-ft. of mission-critical lab and office space, as well as over 100,000 sq.-ft. of amenities. 

 

In targeting LEED Gold certification for BMS’s new development, Alexandria continues to undertake strategic measures to increase energy efficiencies, mitigate carbon emissions, improve redundancy of systems and remove demanding operational requirements from its tenants through a state-of-the-art central plant to be operated by Alexandria